Marlborough, MA, United States of America

Eric C Sigillo

This inventor holds 1 USPTO granted patent. Top assignee: Nova Biomedical Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric C Sigillo. Retrieved from https://idiyas.com/inventor/eric-c-sigillo-s3xnb17g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eric C. Sigillo

Introduction

Eric C. Sigillo is an accomplished inventor based in Marlborough, MA (US). He has made significant contributions to the field of biomolecule quantification through his innovative work. His expertise and dedication to research have led to the development of a unique patent that showcases his skills as an inventor.

Latest Patents

Eric C. Sigillo holds a patent for a "Rapid quantification assay involving concentrated and ligand-coated gold colloid." This invention involves a concentrated and ligand-coated gold colloid and a method for preparing it. The patent also discloses a rapid biomolecule quantification assay that utilizes the concentrated gold colloid, along with an apparatus designed for performing the assay. This innovation has the potential to enhance the efficiency of biomolecule quantification in various applications.

Career Highlights

Eric is currently employed at Nova Biomedical Corporation, where he continues to contribute to advancements in biomedical technology. His work at the company reflects his commitment to improving healthcare solutions through innovative inventions.

Collaborations

Throughout his career, Eric has collaborated with talented individuals such as Mary C. Pomeroy and Catherine A. Saltalamacchia. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Eric C. Sigillo's contributions to the field of biomolecule quantification exemplify the impact of innovation in healthcare. His patent and ongoing work at Nova Biomedical Corporation highlight his role as a significant inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…